Atrium Therapeutics, Inc. (RNA) stock
RNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$6.48+0.05 (+0.78%)
Close on Nov 17, 2026Market cap $110.85MP/E –Yield –
Atrium Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -43.3% | +291.1 |
| Q2 FY2026 | Jun 30, 2026 | -752.9% | −279.2 |
| Q1 FY2026 | Mar 31, 2026 | -88.0% | – |
| Q3 FY2025 | Sep 30, 2025 | -1.7% | – |
| Q2 FY2025 | Jun 30, 2025 | -334.4% | – |
| Q1 FY2025 | Mar 31, 2025 | -473.7% | – |
See a number that looks wrong?